La stimulation à haute fréquence (SHF) du noyau subthalamique (NST) permet de traiter l'ensemble des symptômes moteurs de la maladie de Parkinson (MP), qui n'apparaissent que lorsque 70 % des neurones dopaminergiques de la SNc ont dégénéré. En outre, les mécanismes in fine qui permettent de retarder l'apparition des symptômes moteurs ou qui sous-tendent l'efficacité thérapeutique de la SHF du NST chez l'homme ne sont pas encore élucidés. Notre travail a porté principalement sur l'animal éveillé libre de ses mouvements. <br />Dans une première partie, nous avons analysé les effets de la SHF du NST sur le comportement moteur de rats sains et 6-OHDA et nous avons établi une corrélation entre ces effets et les taux de glutamate et de GABA extracellulaire mesurés par microdialyse intracérébrale au sein de la SNr. Ces données comportementales et neurochimiques couplées à des injections pharmacologiques intranigrales suggèrent que les dyskinésies de la patte avant induites par la SHF du NST sont médiées par le glutamate et fournissent de nouveaux arguments quant aux mécanismes de la SHF du NST dans la MP.<br />Dans une seconde partie nous avons réalisé des microdialyses intracérébrales chez des singes normaux, puis exprimant pleinement les symptômes moteurs induits par le MPTP et enfin après récupération de ces symptômes moteurs dans le but de corréler les déficits et la récupération motrice à des changements de concentration de neurotransmetteurs présents dans deux territoires striataux : le sensori-moteur et le limbique. Notre étude s'est focalisée sur la dopamine et ses métabolites, le glutamate, le GABA et la sérotonine. Nos résultats montrent que les variations de dopamine pourraient jouer un rôle important dans les mécanismes de compensation permettant la récupération de fonctions motrices normales.

Avec l'expérience, nous acquérons une panoplie de règles, associations arbitraires entre des stimuli externes et des actes moteurs, qui nous permettent d'adapter notre comportement à l'environnement (apprentissage associatif conditionnel). Ce type d'apprentissage met en jeu les boucles reliant les ganglions de la base (GGB) et le cortex frontal. Ce travail visait à préciser le rôle des GGB dans l'apprentissage de règles visuo-motrices conditionnelles en utilisant plusieurs approches : 1) l'enregistrement de l'activité des neurones du striatum chez le singe éveillé, 2) l'étude chez des patients atteints de la maladie de Parkinson (une pathologie neurodégénérative touchant les GGB) et 3) la neuroimagerie fonctionnelle chez l'homme sain. Les résultats des trois expériences convergent pour indiquer que les GGB sont impliqués à la fois dans l'acquisition et la rétention des associations visuo-motrices.

No description available.

Des recherches, autant chez l’homme que chez l’animal, proposent qu’il existerait, au sein des réseaux cérébraux, une organisation anatomique parallèle de circuits qui coordonne l’activité des structures qui participent à la planification et à l’exécution d’une action. Dans cette foulée, un modèle émerge qui attribue au cortex préfrontal (CPF) latéral une spécificité anatomo-fonctionnelle basée sur les niveaux de traitement en mémoire de travail (MT). Il s’agit du modèle « niveaux de traitement-dépendant », qui accorde un rôle important au CPF latéral dans l’acquisition et la représentation de règles guidant nos comportements. Des études en neuroimagerie fonctionnelle, utilisant le Wisconsin Card Sorting Task (WCST) ont permis de corroborer ce modèle et de dissocier trois niveaux de traitement en MT non seulement au sein du CPF latéral mais encore aux structures sous- corticales, les ganglions de la base (GB). Ces études suggèrent que certains noyaux des GB seraient topographiquement organisés avec le CPF latéral et contriburaient, sous certaines conditions, à des processus cognitifs et moteurs semblables à leur homologue cortical. Le but de notre étude est d'explorer la généralisation de la contribution des GB et du CPF au modèle niveaux de traitement-dépendant afin de voir si ce dernier est indépendant de la nature des stimuli en mémoire de travail. À cet effet, nous avons modifié le WCST en l’appliquant à un autre domaine, celui du langage. Nous avons remplacé les pictogrammes par des mots et modifié les règles formes, couleurs, nombres, par des règles sémantiques et phonologiques. L’analyse des résultats a démontré que différentes parties des GB de concert avec différentes régions du CPF se différencient quant aux niveaux de traitement en MT et ce, indépendamment de la nature des stimuli. Une deuxième analyse a permis d’évaluer les patrons d’activations liés aux conditions sémantiques et phonologiques. Ces résultats ont mis en évidence que les réseaux préfrontaux semblent liés aux processus exécutifs nécessaires à la réalisation de la tâche, indépendamment de la condition tandis que les aires associatives se dissocient davantage et contiennent des réseaux propres à la sémantique et à la phonologie. / Researches in humans and animals have pointed out the possible existence of a parallel anatomic organization in the core of cerebral networks which could coordinate the activity of different brain regions involved in the planning and execution of an action. Within this framework, the emerging model ascribes an anatomic dissociation to the lateral prefrontal cortex (PFC) based on the level of complexity of the working memory (WM) treatment. This model, namely, the complexity-dependent model, gives an important role to the lateral PFC in the acquiring and representation of the rules guiding our behaviors. This model has been corroborated by functional neuroimaging studies using the Wisconsin Card Sorting Task (WCST). These studies allowed dissociating three levels of complexity of the WM treatment, not restricted to the lateral PFC but also including sub- cortical structures, the basal ganglia (BG), suggesting that some BG nuclei would be topographically organized with the lateral PFC and would contribute to the same cognitive and motor functions. The aim of our study was to investigate whether the BG and the PFC’S contribution to the complexity-dependent model generalizes to different types of stimuli or whether their functions are dependent on the nature of stimuli in WM. To do so, a language version of the WCST was developed to suit a different cognitive domain, i.e. language. The pictograms were replaced with words and rules concerning forms, colors and numbers were substituted with semantic and phonological rules. Data analysis showed that the BG along with the PFC have differential role at different levels of WM processing complexity. In a second analysis, the activation patterns linked to the semantic and phonological conditions were evaluated. Those results indicated that the prefrontal networks seem to be coupled with executive processes needed to perform each condition whereas the employment of different language rules (semantic and phonological) activates specific regions of the phonological and semantic network.

Les antipsychotiques sont utilisés en clinique depuis plus de 50 ans pour pallier aux symptômes de la schizophrénie. Malgré une recherche intensive, les mécanismes cellulaires et moléculaires responsables de l’effet clinique de cette médication demeurent encore nébuleux. Ces drogues sont reconnues comme des antagonistes des récepteurs D2 de la dopamine et peuvent moduler la transcription génique dans le striatum. Au cours des recherches qui ont mené à l'écriture de cette thèse, nous avons exploré l’expression de Nur77, un facteur de transcription de la famille des récepteurs nucléaires, afin de caractériser le rôle de la dopamine, la sérotonine, l’adénosine et le glutamate dans la régulation génique contrôlée par les antagonistes D2. En premier lieu, nous avons examiné l’impact de la co-administration d’agents sérotonergiques et adrénergiques sur l’expression de l’ARNm de Nur77 induite par l’halopéridol, un antipsychotique de première génération. Nous avons observé que le 8-OH-DPAT et le MDL11939 préviennent partiellement l’induction de Nur77 dans le striatum. Au contraire, l’idazoxan potentialise l’effet de l’halopéridol sur l’expression de Nur77 alors que le prazosin reste sans effet. Ces résultats démontrent que l’expression striatale de Nur77 induite par l’halopéridol peut être modulée à la baisse avec un agoniste 5-HT1A ou un antagoniste 5-HT2A. Par la suite, nous avons évalué dans divers paradigmes expérimentaux l’effet de l’éticlopride, un antagoniste spécifique D2, afin d’explorer davantage le mécanisme de l’effet transcriptionnel des antagonistes D2. Étonnamment, la suppression de l’isoforme D2L chez la souris D2L KO ne réduit pas la réponse de l’éticlopride dans le striatum. Par contre, une lésion corticale avec l’acide iboténique bloque l’effet de l’éticlopride sur la transcription de Nur77, suggérant un rôle du glutamate. La combinaison d’un antagoniste des récepteurs métabotropes du glutamate de types 5 (mGluR5) et d’un antagoniste des récepteurs de l’adénosine A2A abolit complètement l’augmentation de la transcription de Nur77 induit par l’éticlopride dans le striatum. La modulation directe de l’expression striatale de Nur77 par les récepteurs mGluR5 et A2A a été confirmée dans un modèle de cultures organotypiques de tranches cérébrales. Ces résultats démontrent clairement que la modulation de l’expression génique dans le striatum, à la suite d’un traitement avec un antagoniste D2 pourrait être indépendante d’une interaction directe avec les récepteurs D2 post-synaptiques, et reposerait plutôt sur son interaction avec les récepteurs D2 hétérosynaptiques des afférences corticostriées et l’activation subséquente des récepteurs post-synaptiques du glutamate et de l’adénosine. En résumé, nos résultats suggèrent que l’interaction des antipsychotiques atypiques avec les récepteurs 5-HT2A et 5-HT1A pourrait expliquer la différence dans le patron d’expression génique induit par ces drogues en comparaison avec les antipsychotiques typiques. De plus, nos résultats révèlent un nouveau mécanisme d’action des antagonistes D2 et supportent un rôle primordial du glutamate et de l’adénosine dans les effets des antipsychotiques de première génération. / Antipsychotic drugs have been used to alleviate schizophrenia symptoms for more than 50 years. Despite extensive research, little is known about the molecular and cellular mechanism responsible for their clinical outcome. These drugs are usually recognized as dopamine D2 antagonists and are known to modulate gene expression in the striatum. In the present thesis, we used the expression of Nur77, a transcription factor of the orphan nuclear receptor family, to explore the role of dopamine, serotonin, glutamate and adenosine receptors in the effect of a dopamine D2 antagonist in the striatum. First, we examined the abilities of serotoninergic and adrenergic receptor drugs to modify the pattern of Nur77 mRNA expression induced by haloperidol, a first generation antipsychotic drug. We observed that 8-OH-DPAT and MDL11939 partially prevent haloperidol-induced Nur77 upregulation. On the contrary, idazoxan consistently potentiated haloperidol-induced Nur77 mRNA levels in the striatum whereas prazosin remained without effect. Taken together, these results show the ability of a 5-HT1A agonist or a 5-HT2A antagonist to reduce haloperidol-induced Nur77 striatal expression. Subsequently, we evaluated in different experimental designs the effect of eticlopride, a specific D2 antagonist, to provide additional information on the mechanism by which D2 antagonist controls transcriptional activity in the striatum. Surprisingly, deletion of the D2L receptor isoform did not reduce eticlopride-induced upregulation of Nur77 mRNA levels in the striatum. However, cortical lesions with ibotenic acid strongly reduced eticlopride-induced upregulation of Nur77 mRNA, suggesting a role for glutamate neurotransmission. A combination of a metabotropic glutamate type 5 (mGluR5) antagonist with an antagonist of its synergistic partner adenosine A2A receptor abolished eticlopride-induced upregulation of Nur77 mRNA levels in the striatum. Direct modulation of striatal Nur77 expression by glutamate and adenosine receptors was confirmed using corticostriatal organotypic cultures. Taken together, these results indicate that modulation of gene expression in the striatum, following a D2 antagonist, might not involve a direct interaction of the drug at postsynaptic D2 receptors, but rather relies on its interaction with corticostriatal presynaptic D2 receptors and subsequent activation of postsynaptic glutamate and adenosine receptors in the striatum. In summary, our results suggest that interaction of atypical antipsychotic drugs with 5-HT2A and 5-HT1A receptors participate in the differential pattern of gene expression induced by these drugs when compared with typical antipsychotic drugs. Moreover, our results uncover a new mechanism of action of D2 antagonists and support a prominent role of glutamate and adenosine in the effect of classic antipsychotic drugs.

Ce travail porte sur l'étude fonctionnelle de deux gènes préférentiellement exprimés dans deux régions du cerveau touchées par des pathologies neurodégénératives : Capucine, un marqueur du striatum, structure qui dégénère au cours de la maladie de Huntington et Agpat4, un marqueur de l'aire tegmentaire ventrale et de la substance noire compacte, dont les neurones dopaminergiques sont sélectivement atteints lors de la maladie de Parkinson. Des lignées de souris invalidées pour ces gènes ont été générées au laboratoire et au cours de ma thèse j'ai procédé à leur caractérisation. L'expression striatale du gène de la Capucine étant significativement diminuée dans des modèles murins de la maladie de Huntington, nous avons souhaité évaluer son rôle éventuel dans la pathogenèse de cette maladie. Pour ce faire, nous avons examiné, dans le cadre d'une collaboration, l'effet du knock-out et de la surexpression du gène de la Capucine sur la vulnérabilité des neurones striataux à un fragment de la Huntingtine mutée dans un modèle murin de la maladie de Huntington. Les données montrent que la Capucine n'a pas d'effet significatif sur la toxicité du fragment de la Huntingtine mutée dans le modèle étudié.La protéine Agpat4 présente des homologies de séquence avec des acyltransférases impliquées dans le métabolisme des phosphoglycérides. J'ai réalisé des études d'expression par différentes techniques de biologie moléculaire qui montrent que le gène d'Agpat4 est exprimé dans la plupart des tissus catécholaminergiques. Pour déterminer l'activité endogène d'Agpat4 et son rôle physiologique dans les tissus où elle est exprimée, j'ai comparé le métabolome de tissus de souris invalidées pour le gène d'Agpat4 et sauvages par chromatographie en phase liquide couplée à la spectrométrie de masse. Mes résultats indiquent que l'invalidation du gène d'Agpat4 perturbe le métabolisme non seulement de différentes classes de lipides, notamment les lysophosphatidyléthanolamines, mais aussi celui des catécholamines.

The developing brain goes through a number of developmental periods during which it displays an increased sensitivity to exogenous disturbances. On such period is the so called “Brain growth spurt” (BGS) which in humans takes place starting from the third trimester of pregnancy and throughout the first few years of life. The corresponding period in rats and mice is the first postnatal weeks. Exposure to relatively modest concentrations of the brominated flame retardant PBDE-99 during the second week of life in mice causes a more or less permanent impairment in the ability of the animals to adjust properly to environmental changes at adulthood. This “late response on early exposure” reflects the long-term consequences of disrupting the developing brain during a sensitive time period. The cellular mechanisms underlying the behavioral effects are far from clear. To address the initial damage occurring around the time of exposure, the approach used in this thesis is to use proteomics to analyze the effects of PBDE-99 on protein expression soon (24 hours) after exposure of the neonatal mouse on postnatal day (PND) 10.The thesis comprises the effects on the proteome in three distinct brain parts: cerebral cortex, striatum and the hippocampus. In addition, an in vitro model was developed and used to evaluate the PBDE-99 effects on cultured cerebral cortex cells from embryonic rat brains. Gel-based proteomics (2D-DIGE) coupled to MALDI- or ESI-MS has been used throughout for the proteomics experiments, but other techniques aimed at analyzing both proteins and mRNA have also been used to better characterize the effects. Even if the protein complements expressed by the different brain parts and separated with 2D-DIGE are seemingly similar, the effects are apparently specific for the different brain regions. In hippocampus, PBDE induces effects on proteins involved in metabolism and energy production, while the effects in striatum point towards effects on neuroplasticity. PBDE-99 changes the expression of cytoskeletal proteins in the cerebral cortex 24 hours after exposure. Interestingly, in vitro exposure of cerebral cortex cells to a PBDE-99 concentration in the same order of magnitude as in the in vivo neonatal brain also induces cytoskeletal effects, in the absence of cytotoxicity. This may suggest effects on regulatory aspects of cytoskeletal dynamics such as those involved in neurite sprouting. This thesis also addresses the problems involved in presenting proteomics data. Many of the available methods and approaches for presenting transcriptomics data are not suitable for isoform rich protein data. Modifications of existing methods and the development of a new approach (DEPPS) is also presented. Most importantly, the thesis presents the application and usefulness of proteomics as hypothesis generating techniques in neurotoxicology.

Coordenação de Aperfeiçoamento de Pessoal de Nível Superior / Glutaric acidemia type I (GA-I) is an inborn error of metabolism (EIM), characterized biochemically by major accumulation of glutaric acid (GA) and pathologically by a characteristic striatal degeneration. The clinical manifestations are mainly neurological and develop during childhood (up to 5 years old). Among these changes, there are the seizures and cognitive deficits, which may be precipitated by infectious processes. From this, the first hypothesis to be tested in this study was to investigate whether lipopolysaccharide E. coli 055 B5 serotype (LPS; 2 mg/Kg; i.p.), an inflammatory agent, could facilitate seizures induced by GA in young rats (21 days of life). For this, firstly it was determined the acute dose of intrastriatal GA (1.3 μmol/striatum) that cause behavioral and electroencephalographic (EEG) seizures in young rats. Moreover, it was shown that LPS administration 3 hours before GA intrastriatal injection did not change the seizures, but when LPS was administered 6 hours before the GA, it reduced the latency and increased the duration of behavioral and EEG seizures induced by GA in young rats. It also was observed that LPS injection caused an initial drop in rectal temperature of young rats (up to 2 hours), followed by a rise in temperature that started at 3 hours and remained high until 6 hours after LPS injection. Furthermore, it was shown that LPS injection 3 and 6 hours before intrastriatal injection of GA caused an increase in striatal levels of IL-1β in young rats, and this increase was statistically higher in 6 than in 3 hours. In addition, it was observed that the increase in IL-1β striatal levels, caused by LPS administration, positively correlated with total time of seizures. Finally, it was observed that previous use of IL-1β antibody prevented the latency reduction and the increased duration of seizures caused by LPS administration 6 h before intrastriatal injection of GA in young rats. Thus, these findings suggest that the signaling of IL-1β present in inflammation produced by LPS contributes significantly to neuronal hyperexcitability, and thus to reduce latency and increase the duration of seizures induced by GA. Therefore, pharmacological treatments that block the specific functions or overproduction of IL-1β in GA-I, may represent an unconventional strategy to treat this condition. However, clinical studies should be conducted to evaluate the effectiveness of treatment in glutaricoacidemic patients with convulsions. Since patients with GA-I have other important neurological changes addition to the seizures, as cognitive impairments, the second hypothesis to be tested in this study was to determine whether chronic treatment with GA (5 μmol/g; s.c.; twice per day; from the 5th to the 28th day of life) could cause spatial memory impairment in young rats, and verify whether the inflammation produced by LPS (2 mg/Kg; i.p.; one per day; from the 25th to the 28th day of life) could facilitate the cognitive deficit induced by GA. In addition, it also was evaluated the possible impact of these treatments on functional and structural changes in the hippocampus of these animals. Initially it was shown that chronic treatment with GA, as well as the treatments with LPS and GA-LPS, caused a deficit in spatial learning of young rats. However, it was demonstrated that the treatment with GA-LPS produced a greater impairment in spatial memory compared to other treatments. In addition, it was observed that none of the treatments affected weight or locomotor activity/exploratory of animals. It also was shown that chronic treatment with GA, as well as treatments with LPS and GA-LPS, increased the hippocampal levels of IL-1β and TNF-α in young rats. Furthermore, it was demonstrated that treatments with GA, LPS and GA-LPS caused a reduction in total hippocampal volume of young rats. Finally it was observed that treatments with GA, LPS and GA-LPS caused a reduction of α1 subunit activity of Na+,K+-ATPase enzyme. On the other hand, it was shown that treatments with GA and LPS caused an increase in activity of α2/3 subunits of the enzyme. Thus, only treatment with GA-LPS showed a reduction in total activity of Na+,K+-ATPase in the hippocampus of young rats. These data indicate that the impairment in spatial learning observed in rats treated with GA, LPS and GA-LPS was due to increased levels of inflammatory cytokines, the reduction in hippocampal volume and the inhibition of α1 subunit activity of Na+,K+-ATPase enzyme. However, the worsening in spatial memory observed in rats treated with GA-LPS was due to inhibition of total activity of Na+,K+-ATPase, which was specific α2/3 isoforms, since only this group showed no compensatory response the activity of these subunits. Therefore, this second part of the study showed that chronic treatment with GA caused a deficit in spatial learning in young rats, and that the presence of an inflammatory process increased the impairment in spatial memory induced by GA alone. Thus, understanding the mechanisms involved in seizures and cognitive deficits observed in patients with GA-I in the presence of an inflammatory process is important for the development of new therapies to treat this condition, as well as other diseases associated with the presence of inflammatory mediators. / A acidemia glutárica tipo I (GA-I) é um erro inato do metabolismo (EIM) caracterizada bioquimicamente pelo acúmulo principal de ácido glutárico (GA) e patologicamente por uma característica degeneração estriatal. As manifestações clínicas são predominantemente neurológicas, e desenvolvem-se principalmente na infância (até os 5 anos de idade). Entre estas alterações, destacam-se as convulsões e os déficits cognitivos, os quais podem ser precipitados por processos infecciosos. A partir disso, a primeira hipótese a ser testada neste estudo foi investigar se o lipopolissacarídeo sorotipo E. coli 055 B5 (LPS; 2 mg/Kg; i.p.), um agente inflamatório, facilitaria as convulsões induzidas pelo GA em ratos jovens. Para isso, primeiramente determinou-se a dose intraestriatal aguda de GA (1.3 μmol/estriado) que causa convulsões comportamentais e eletroencefalográficas (EEG) em ratos jovens (21 dias). Em seguida foi verificado que a administração de LPS 3 horas antes da injeção intraestriatal de GA não alterou as convulsões, mas quando o LPS foi administrado 6 horas antes do GA, ele reduziu a latência e aumentou a duração das convulsões comportamentais e EEG induzidas pelo GA em ratos jovens. Observou-se também que injeção de LPS causou uma queda inicial na temperatura retal dos ratos jovens (até 2 horas), seguida de uma elevação na temperatura que iniciou em 3 horas e permaneceu alta até 6 horas após a injeção de LPS. Além disso, foi verificado que injeção de LPS 3 e 6 horas antes da injeção intraestriatal de GA causou um aumento nos níveis estriatais de IL-1β nos ratos jovens, sendo esse aumento estatisticamente maior em 6 do que em 3 horas. Também foi observado que o aumento nos níveis estriatais de IL-1β, causado pela administração de LPS, correlacionou-se positivamente com o tempo total de convulsões. Por fim, verificou-se que uso prévio do anticorpo da IL-1β preveniu a redução da latência e o aumento da duração das convulsões causadas pela administração de LPS 6 horas antes da injeção intraestriatal de GA nos ratos jovens. Assim, estes achados sugerem que a sinalização da IL-1β presente no processo inflamatório produzido pelo LPS contribui decisivamente para a hiperexcitabilidade neuronal e, consequentemente, para a redução da latência e o aumento da duração das convulsões induzidas pelo GA. Dessa maneira, tratamentos farmacológicos específicos que bloqueiam a superprodução ou as funções da IL-1β na GA-I, podem representar uma estratégia não convencional para o tratamento dessa patologia. Entretanto, estudos clínicos devem ser realizados a fim de avaliar a eficácia desse tratamento nos pacientes glutaricoacidêmicos que apresentam convulsões. Desde que os pacientes com GA-I apresentam outras alterações neurológicas importantes além das convulsões, como prejuízos cognitivos, a segunda hipótese a ser testada neste estudo foi verificar se o tratamento crônico com GA (5 μmol/g; s.c.; duas vezes por dia; do 5° ao 28° dia de vida) causaria déficit de memória espacial em ratos jovens, bem como se a inflamação produzida pelo LPS (2 mg/Kg; i.p.; uma vez por dia; do 25° ao 28° dia de vida) facilitaria o déficit cognitivo induzido pelo GA. Além disso, também foi objetivo avaliar o impacto desses tratamentos sobre possíveis alterações funcionais e estruturais no hipocampo desses animais. Inicialmente verificou-se que o tratamento crônico com GA, assim como os tratamentos com LPS e GA-LPS, causaram um déficit no aprendizado espacial dos ratos jovens. No entanto, foi observado que o tratamento com GA-LPS produziu um maior prejuízo na memória espacial comparado com os outros tratamentos. Em seguida foi observado que nenhum dos tratamentos alterou o peso ou a atividade locomotora/exploratória dos animais. Verificou-se também que o tratamento crônico com GA, assim como os tratamentos com LPS e GA-LPS, aumentaram os níveis hipocampais de IL-1β e TNF-α nos ratos jovens. Além disso, foi observado que tratamentos com GA, LPS e GA-LPS causaram uma redução no volume hipocampal total dos ratos jovens. Finalmente verificou-se que os tratamentos com GA, LPS e GA-LPS causaram uma redução na atividade da subunidade α1 da enzima Na+,K+-ATPase. Por outro lado, foi observado que os tratamentos com GA e LPS causaram um aumento na atividade das subunidades α2/3 da enzima. Assim, somente o tratamento com GA-LPS apresentou uma redução na atividade total da enzima Na+,K+-ATPase no hipocampo dos ratos jovens. Estes dados indicam que o prejuízo no aprendizado espacial observado nos ratos tratados com GA, LPS e GA-LPS parece estar relacionado a um aumento nos níveis de citocinas inflamatórias, a uma redução no volume hipocampal e a uma inibição na atividade da subunidade α1 da enzima Na+,K+-ATPase. No entanto, o maior prejuízo na memória espacial observado nos ratos tratados com GA-LPS ocorreu devido a inibição na atividade total da enzima Na+,K+-ATPase, que foi específica das isoformas α2/3, já que somente este grupo não apresentou resposta compensatória na atividade destas subunidades. Portanto, esta segunda parte do estudo demonstrou que o tratamento crônico com GA causou um déficit no aprendizado espacial de ratos jovens, e que a presença de um processo inflamatório potencializou o prejuízo na memória espacial induzida pelo GA sozinho. Assim, o entendimento dos mecanismos envolvidos nas convulsões e no déficit cognitivo observados nos paciente com GA-I frente a um processo inflamatório é importante para o desenvolvimento de novas terapias para o tratamento dessa patologia, bem como de outras doenças associadas à presença de mediadores inflamatórios.

O gênero Psychotria destaca-se na família RUBIACEAE pela produção de alcalóides bioativos e por sua taxonomia complexa, sendo muitas vezes relacionado aos gêneros Palicourea, Cephaelis, Calycodendron e Calycosia. A divisão de Psychotria nos subgêneros Psychotria, Tetramerae e Heteropsychotria foi proposta com o objetivo de auxiliar a classificação quimiotaxonômica do gênero. Estudos demonstram que o subgênero Psychotria (espécies pantropicais) produz alcalóides poliméricos, formados por duas ou mais unidades de triptamina; enquanto o subgênero Heteropsychotria parece estar envolvido com a produção de alcalóides indol monoterpênicos, de acordo com pesquisas realizadas com diferentes espécies coletadas no Sul do Brasil. O isolamento e purificação dos alcalóides estrictosamida, ácido estrictosidínico e miriantosina, a partir de Psychotria myriantha, corroboram com esta hipótese, permitindo a inclusão da espécie no subgênero Heteropsychotria. A literatura descreve várias atividades para extratos e alcalóides isolados de espécies de Psychotria, como antimicrobiana e analgésica, por exemplo. Neste trabalho, o extrato n-butanólico de alcalóides de P. myriantha, além de seus alcalóides isolados, apresentaram atividade inibidora da migração de leucócitos, sugerindo um efeito antiinflamatório, e capacidade de inibir a ação da enzima acetilcolinesterase. Extratos e alcalóides isolados da espécie foram avaliados quanto à atividade antioxidante em CCD, frente ao DPPH, apresentando resultado negativo. O extrato EBA e o alcalóide ácido estrictosidínico aumentaram o tempo de latência no teste da retirada da cauda frente ao estímulo térmico, indicando uma atividade analgésica do tipo opióide. A influência do ácido estrictosidínico, alcalóide isolado em maior quantidade em massa, sobre os níveis de DA, DOPAC, 3-MT, HVA, 5-HT e 5-HIAA em estruturas cerebrais de ratos foi verificada. Hipocampos de animais que receberam injeção intra-hipocampal bilateral de ácido estrictosidínico (20 μg/μL) apresentaram redução de 83,4 % nos níveis de serotonina, em comparação ao grupo controle, enquanto os córtices desses animais apresentaram redução nos níveis de DOPAC (35,9%), 3-MT (24,7%) e 5-HIAA (9%). Hipocampos e estriados de ratos tratados com injeção i.p. de ácido estrictosidínico (10 mg/kg) demonstraram diminuição de 63,4 e 28,7% nos níveis de 5-HT, respectivamente. As alterações nos níveis de aminas biogênicas nas estruturas avaliadas, além das atividades analgésica e inibidora da acetilcolinesterase, indicam que P. myriantha e espécies do subgênero Heteropsychotria constituem uma potencial fonte de substâncias bioativas no tratamento de distúrbios do sistema nervoso central. / Psychotria genus is an important in RUBIACEAE due to bioactive alkaloids production and complex taxonomy, being related to Palicourea, Cephaelis, Calycodendron and Calycosia genera. The division of Psychotria in Psychotria, Tetramerae and Heteropsychotria subgenera was proposed with the aim of aiding the genus chemotaxonomic classification. Studies demonstrate that Psychotria subgenus produce polyindoline alkaloids formed by two or more triptamine units; whereas Heteropsychotria subgenus seems to be involved with indole monoterpene alkaloids production, according to researches with different species collected in Southern Brazil. Isolation and purification of strictosamide, strictosidinic acid and miriantosine from Psychotria myriantha corroborated this hypothesis, allowing its inclusion into Heteropsychotria subgenus. The scientific literature describes several activities to Psychotria extracts and alkaloids, such as antimicrobial and analgesic, for example. In this work, P. myriantha n-butanolic alkaloid extract and isolated compounds inhibited the leukocyte migration, suggesting an antiinflammatory activity, and a weak ability to inhibit the action of acetylcholinesterase enzyme. Alkaloids and extracts from P. myriantha were evaluated as regards their antioxidant activity using DPPH, with no positive results. EBA and strictosidinic acid increased the latency in the tail flick model, indicating an opioid analgesic activity. The influence of strictosidinic acid on the levels of DA, DOPAC, 3-MT, HVA, 5-HT and 5-HIAA in brain structures of rats was verified. Hippocampus with intra-hippocampal injection of strictosidinic acid (20 μg/μL) displayed a decrease of 83.4% in serotonin levels, in comparison with control group; whereas the cortex showed a decrease in the levels of DOPAC (35.9%), 3-MT (24.7%) and 5-HIAA (9%). Hippocampus and striatum that received intraperitoneal injection of strictosidinic acid (10 mg/kg) showed 5-HT levels reduction of 63.4 e 28.7%, respectively. The biogenic amine levels alterations in the studied structures, associated with the analgesic and acetylcholinesterase inhibitor activities, suggest that P. myriantha and species from the Heteropsychotria subgenus constitute a font of bioactive compounds in the treatment of central nervous system disturbs.

O gênero Psychotria destaca-se na família RUBIACEAE pela produção de alcalóides bioativos e por sua taxonomia complexa, sendo muitas vezes relacionado aos gêneros Palicourea, Cephaelis, Calycodendron e Calycosia. A divisão de Psychotria nos subgêneros Psychotria, Tetramerae e Heteropsychotria foi proposta com o objetivo de auxiliar a classificação quimiotaxonômica do gênero. Estudos demonstram que o subgênero Psychotria (espécies pantropicais) produz alcalóides poliméricos, formados por duas ou mais unidades de triptamina; enquanto o subgênero Heteropsychotria parece estar envolvido com a produção de alcalóides indol monoterpênicos, de acordo com pesquisas realizadas com diferentes espécies coletadas no Sul do Brasil. O isolamento e purificação dos alcalóides estrictosamida, ácido estrictosidínico e miriantosina, a partir de Psychotria myriantha, corroboram com esta hipótese, permitindo a inclusão da espécie no subgênero Heteropsychotria. A literatura descreve várias atividades para extratos e alcalóides isolados de espécies de Psychotria, como antimicrobiana e analgésica, por exemplo. Neste trabalho, o extrato n-butanólico de alcalóides de P. myriantha, além de seus alcalóides isolados, apresentaram atividade inibidora da migração de leucócitos, sugerindo um efeito antiinflamatório, e capacidade de inibir a ação da enzima acetilcolinesterase. Extratos e alcalóides isolados da espécie foram avaliados quanto à atividade antioxidante em CCD, frente ao DPPH, apresentando resultado negativo. O extrato EBA e o alcalóide ácido estrictosidínico aumentaram o tempo de latência no teste da retirada da cauda frente ao estímulo térmico, indicando uma atividade analgésica do tipo opióide. A influência do ácido estrictosidínico, alcalóide isolado em maior quantidade em massa, sobre os níveis de DA, DOPAC, 3-MT, HVA, 5-HT e 5-HIAA em estruturas cerebrais de ratos foi verificada. Hipocampos de animais que receberam injeção intra-hipocampal bilateral de ácido estrictosidínico (20 μg/μL) apresentaram redução de 83,4 % nos níveis de serotonina, em comparação ao grupo controle, enquanto os córtices desses animais apresentaram redução nos níveis de DOPAC (35,9%), 3-MT (24,7%) e 5-HIAA (9%). Hipocampos e estriados de ratos tratados com injeção i.p. de ácido estrictosidínico (10 mg/kg) demonstraram diminuição de 63,4 e 28,7% nos níveis de 5-HT, respectivamente. As alterações nos níveis de aminas biogênicas nas estruturas avaliadas, além das atividades analgésica e inibidora da acetilcolinesterase, indicam que P. myriantha e espécies do subgênero Heteropsychotria constituem uma potencial fonte de substâncias bioativas no tratamento de distúrbios do sistema nervoso central. / Psychotria genus is an important in RUBIACEAE due to bioactive alkaloids production and complex taxonomy, being related to Palicourea, Cephaelis, Calycodendron and Calycosia genera. The division of Psychotria in Psychotria, Tetramerae and Heteropsychotria subgenera was proposed with the aim of aiding the genus chemotaxonomic classification. Studies demonstrate that Psychotria subgenus produce polyindoline alkaloids formed by two or more triptamine units; whereas Heteropsychotria subgenus seems to be involved with indole monoterpene alkaloids production, according to researches with different species collected in Southern Brazil. Isolation and purification of strictosamide, strictosidinic acid and miriantosine from Psychotria myriantha corroborated this hypothesis, allowing its inclusion into Heteropsychotria subgenus. The scientific literature describes several activities to Psychotria extracts and alkaloids, such as antimicrobial and analgesic, for example. In this work, P. myriantha n-butanolic alkaloid extract and isolated compounds inhibited the leukocyte migration, suggesting an antiinflammatory activity, and a weak ability to inhibit the action of acetylcholinesterase enzyme. Alkaloids and extracts from P. myriantha were evaluated as regards their antioxidant activity using DPPH, with no positive results. EBA and strictosidinic acid increased the latency in the tail flick model, indicating an opioid analgesic activity. The influence of strictosidinic acid on the levels of DA, DOPAC, 3-MT, HVA, 5-HT and 5-HIAA in brain structures of rats was verified. Hippocampus with intra-hippocampal injection of strictosidinic acid (20 μg/μL) displayed a decrease of 83.4% in serotonin levels, in comparison with control group; whereas the cortex showed a decrease in the levels of DOPAC (35.9%), 3-MT (24.7%) and 5-HIAA (9%). Hippocampus and striatum that received intraperitoneal injection of strictosidinic acid (10 mg/kg) showed 5-HT levels reduction of 63.4 e 28.7%, respectively. The biogenic amine levels alterations in the studied structures, associated with the analgesic and acetylcholinesterase inhibitor activities, suggest that P. myriantha and species from the Heteropsychotria subgenus constitute a font of bioactive compounds in the treatment of central nervous system disturbs.